Basal Cell Carcinoma

  • Roberto Gomes TarléEmail author
  • Wagner Bertolini
  • Luciano José Biasi
  • José Roberto Toshio Shibue


Basal cell carcinoma (BCC) is the most incident type of skin cancer, having been related etiologically to chronic sun exposure and genetic predisposition. The classical clinical presentation of BCC is a slow-growing pearly papule, showing telangiectatic vessels that can progress to nodules. Different clinical and histologic subtypes are described, whose recognition is of great importance in arriving at the correct therapeutic decision and oncologic cure.


Basal cell carcinoma Skin cancer Nonmelanoma skin cancer 



Confocal microscopy

Noninvasive imaging technique that enables in vivo visualization of the skin structure in real time.


Noninvasive diagnostic technique for the in vivo observation of skin lesions with a dermatoscope, allowing magnification of the lesion.

Gorlin’s syndrome

Also known as nevoid basal cell carcinoma syndrome, it is characterized by developmental anomalies, such as odontogenic keratocysts of the mandible, bifid ribs, palmoplantar pits and tumors, and especially multiple BCCs.

Mohs micrographic surgery

A microscopically controlled surgery used to treat different types of skin cancer, developed in 1938 by Frederic Mohs.

Optical coherence tomography

Noninvasive imaging examination that uses light waves to take cross-sectional pictures of the skin structure.

Photodynamic therapy

Treatment that uses a photosensitizer or photosensitizing agent that will be absorbed by the target cell, and a particular type of light that will react with the photosensitizer and cause cellular death.

PTCH1, patched 1 gene

This gene encodes the protein receptor for the sonic hedgehog, a molecule implicated in the formation of embryonic structures and in tumorigenesis. Mutations of this gene have been associated with basal cell nevus syndrome and sporadic BCC.


Dilated capillaries that appear clinically as red linear vessels with spidery appearance on the surface of the skin.


  1. 1.
    Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80.CrossRefPubMedGoogle Scholar
  2. 2.
    Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol. 2011;86(2):292–305.CrossRefPubMedGoogle Scholar
  3. 3.
    Cancer INd. Câncer de Pele Não Melanoma (Cited 2016 30 Apr).
  4. 4.
    Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol. 2015;151(9):976–81.CrossRefPubMedGoogle Scholar
  5. 5.
    Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294(6):681–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y, et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol. 2010;12(3):299–305.CrossRefPubMedGoogle Scholar
  7. 7.
    Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol: EJD. 2014;24(3):312–29.PubMedGoogle Scholar
  8. 8.
    Lin AN, Carter DM, Balin AK. Nonmelanoma skin cancers in the elderly. Clin Geriatr Med. 1989;5(1):161–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Colins S. Basal cell carcinoma. Clinical presentation. In: Miller SJ MM, editor. Cutaneous oncology. Malden, MA: 1: Wiley-Blackwell; 1998. pp. 625–32.Google Scholar
  10. 10.
    Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol. 2000;136(8):1012–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Lallas A, Tzellos T, Kyrgidis A, Apalla Z, Zalaudek I, Karatolias A, et al. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014;70(2):303–11.CrossRefPubMedGoogle Scholar
  12. 12.
    Telfer NR, Colver GB, Morton CA, British Association of D. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.CrossRefPubMedGoogle Scholar
  13. 13.
    Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol: Off J US Can Acad Pathol Inc. 2006;19(Suppl 2):S127–47.CrossRefGoogle Scholar
  14. 14.
    Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003;148(2):195–202.CrossRefPubMedGoogle Scholar
  15. 15.
    Ratner D, Lowe L, Johnson TM, Fader DJ. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer. 2000;88(7):1605–13.CrossRefPubMedGoogle Scholar
  16. 16.
    Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, et al. Basal cell carcinoma: a comprehensive review for the radiologist. AJR Am J Roentgenol. 2015;204(2):W132–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Schwartz R. Basal Cell Carcinoma. In: Schwartz R, editor. Skin cancer: recognition and management. Malden: Blackwell Publishing; 2008. p. 87–104.CrossRefGoogle Scholar
  18. 18.
    Arits AH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14(7):647–54.CrossRefPubMedGoogle Scholar
  19. 19.
    Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol: EJD. 2008;18(5):547–53.PubMedGoogle Scholar
  20. 20.
    Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol. 1991;17(7):574–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Roberto Gomes Tarlé
    • 1
    Email author
  • Wagner Bertolini
    • 2
  • Luciano José Biasi
    • 3
  • José Roberto Toshio Shibue
    • 4
  1. 1.Santa Casa de Misericórdia Pontifical Catholic University of Paraná – PUCPRCuritibaBrazil
  2. 2.Santa Casa HospitalPorto AlegreBrazil
  3. 3.Instituto de Oncologia do ParanáCuritibaBrazil
  4. 4.Santa Casa de Curitiba, Instituto de Neurologia de CuritibaCuritibaBrazil

Personalised recommendations